Finally, A Real Cure for HIV

 Using CRISPR-Cas9 tools, Excision is moving a treatment into human trials. 

EBT-101 has since been tested in nonhuman primates, which showed it reached every tissue in the body where HIV reservoirs reside.

Excision licensed the therapy from the universities with a goal of moving it into clinical trials. Now, the FDA is on board.